Hope in the Pipeline
Hope in the Pipeline
Podcast Description
Tomorrow’s Medicine, Today’s Breakthroughs at Preferred Research Partners hosted by Dr. Paul E. Wylie.
Podcast Insights
Content Themes
The podcast focuses on topics related to mental health, particularly social anxiety and the use of psychedelics in treatment. Episodes include detailed discussions on the symptoms and treatment options for anxiety disorders, as well as the innovative use of psychedelics for addressing mood disorders and promoting neuroplasticity. Specific episodes highlight clinical trials and the evolving landscape of psychiatric treatments.
Tomorrow’s Medicine, Today’s Breakthroughs at Preferred Research Partners hosted by Dr. Paul E. Wylie.
Welcome to the third part of our Hope in the Pipeline series on hypersomnolence disorders. In this episode, we dive deep into:
🔹 Medications used to treat narcolepsy – from older stimulants to newer, longer-lasting options
🔹 The role of antidepressants and sodium oxybate in managing symptoms like cataplexy
🔹 Key differences between narcolepsy and idiopathic hypersomnia (IH)
🔹 Current treatment options for IH and why diagnosis can be so challenging
🔹 Exciting ongoing clinical research at Preferred Research Partners, including a new potential therapy targeting narcolepsy and IH
Disclaimer
This podcast’s information is provided for general reference and was obtained from publicly accessible sources. The Podcast Collaborative neither produces nor verifies the content, accuracy, or suitability of this podcast. Views and opinions belong solely to the podcast creators and guests.
For a complete disclaimer, please see our Full Disclaimer on the archive page. The Podcast Collaborative bears no responsibility for the podcast’s themes, language, or overall content. Listener discretion is advised. Read our Terms of Use and Privacy Policy for more details.